← Leaderboards
Susan J Hayflick
Oregon Health And Science University
$5,778,640
Attributed
$5,778,640
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $786.6K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$5,778,640 · 7
By mechanism
R01$5,210,023 · 3
R21$423,500 · 1
M01$80,117 · 1
R13$65,000 · 2
Top collaborators
No co-investigators on record.
Most similar at Oregon Health And Science University
Same institution · by research overlap
- Penelope Hogarth$2,643,080
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeGeneticBrainGenesModel Design /DevelopmentCoenzyme ADisease /Disorder ModelGene ExpressionElectroretinographyPathogenesisDefectMolecularNeurodegenerative DisordersRetinitis PigmentosaTranslatingMagnetic Resonance ImagingFunctional DisorderClinical ResearchMouse ModelHallervorden-Spatz SyndromeHuman SubjectGene MutationMetabolicMitochondria
Grant awards (21)
PKAN pathogenesis and treatment$336,875
R01 · FY2020 · NS · contact PI
PKAN pathogenesis and treatment$336,875
R01 · FY2019 · NS · contact PI
PKAN pathogenesis and treatment$336,875
R01 · FY2018 · NS · contact PI
Coenzyme A replenishment as a therapeutic strategy for inborn errors of metabolism$192,500
R21 · FY2018 · HD · contact PI
Coenzyme A replenishment as a therapeutic strategy for inborn errors of metabolism$231,000
R21 · FY2017 · HD · contact PI
An international scientific conference on NBIA disorders$23,000
R13 · FY2016 · NS · contact PI
The Molecular Basis of Infantile Neuroaxonal Dystrophy$256,452
R01 · FY2008 · HD · contact PI
The Molecular Basis of Syndromic Retinitis Pigmentosa$389,623
R01 · FY2007 · EY · contact PI
The Molecular Basis of Infantile Neuroaxonal Dystrophy$261,401
R01 · FY2007 · HD · contact PI
The Molecular Basis of Syndromic Retinitis Pigmentosa$522,337
R01 · FY2006 · EY · contact PI
The Molecular Basis of Infantile Neuroaxonal Dystrophy$264,269
R01 · FY2006 · HD · contact PI
The Molecular Basis of Syndromic Retinitis Pigmentosa$378,213
R01 · FY2005 · EY
A PILOT STUDY TO DELINEATE BIOCHEMICAL PHENOTYPE AND CLINICAL OUTCOME MEASURES$39,174
M01 · FY2005 · RR
The Molecular Basis of Syndromic Retinitis Pigmentosa$36,188
R01 · FY2005 · EY
Molecular Basis of Syndromic Retinitis Pigmentosa$382,632
R01 · FY2004 · EY
A Pilot Study to Delineate Biochemical Phenotype and Clinical Outcome Measures$40,943
M01 · FY2004 · RR
MOLECULAR BASIS OF SYNDROMIC RETINITIS PIGMENTOSA$492,945
R01 · FY2003 · EY
MOLECULAR BASIS OF SYNDROMIC RETINITIS PIGMENTOSA$492,304
R01 · FY2002 · EY
MOLECULAR BASIS OF SYNDROMIC RETINITIS PIGMENTOSA$456,266
R01 · FY2001 · EY
MOLECULAR BASIS OF SYNDROMIC RETINITIS PIGMENTOSA$266,768
R01 · FY2000 · EY
FIRST SCIENTIFIC WORKSHOP ON HALLERVORDEN-SPATZ SYNDROME$42,000
R13 · FY2000 · NS